The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis

The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis

Abstract Objective We aim to evaluate the relationship between the use of metformin and the risk of pancreatic cancer in type 2 diabetes patients. Method We systematically searched the observational studies on PubMed, Embase, Web of Science, Cochrane Library, clinicalrials.gov, and CNKI databases, e...

Full description

Bibliographic Details
Main Authors:	Jian Hu, Hong-Dan Fan, Jian-Ping Gong, Qing-Song Mao
Format:	Article
Language:	English
Published:	BMC 2023-02-01
Series:	BMC Gastroenterology
Subjects:	Metformin Pancreatic cancer Diabetes mellitus Meta-analysis
Online Access:	https://doi.org/10.1186/s12876-023-02671-0

Similar Items

The relationship between metformin consumption and cancer risk: An updated umbrella review of systematic reviews and meta-analyses
by: Farid Najafi, et al.
Published: (2023-01-01)

Survival Benefit of Metformin Use for Pancreatic Cancer Patients Who Underwent Pancreatectomy: Results From a Meta-Analysis
by: Junqiang Zhang, et al.
Published: (2020-07-01)

Clinical effect of metformin in children and adolescents with type 2 diabetes mellitus: A systematic review and meta-analysis
by: Mohammed A Al-Shareef, et al.
Published: (2012-01-01)

Comparative and Combined Synergetic Effects of Black Coffee and Metformin in Treatment of Type 2 Diabetes Mellitus
by: Jawaria Iftikhar, Uzma Naeem, Tahira Sadiq
Published: (2019-03-01)

Impact of metformin on the risk and treatment outcomes of tuberculosis in diabetics: a systematic review
by: Xinyu Yu, et al.
Published: (2019-10-01)

Association of preadmission metformin use and mortality in patients with sepsis and diabetes mellitus: a systematic review and meta-analysis of cohort studies
by: Huoyan Liang, et al.
Published: (2019-02-01)

Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
by: Ke Chen, et al.
Published: (2017-07-01)

Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
by: Claudio Vernieri, et al.
Published: (2019-09-01)

Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis
by: Dan-Qing Yu, et al.
Published: (2021-10-01)

Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Ziting Liang, et al.
Published: (2022-08-01)

The efficacy of Da Chaihu decoction combined with metformin tablets for type 2 diabetes mellitus: A systematic review and meta-analysis
by: Jia-bin Wang, et al.
Published: (2022-12-01)

Meta-analysis: The efficacy of metformin and other anti-hyperglycemic agents in prolonging the survival of hepatocellular carcinoma patients with type 2 diabetes
by: Jian Zhou, et al.
Published: (2020-05-01)

Anticancer effects of metformin in experimental animal models of different types of cancer: a systematic review and meta-analysis
by: Fan Zhang, et al.
Published: (2022-07-01)

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis
by: Kang Yang, et al.
Published: (2023-07-01)

Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis
by: Rao M, et al.
Published: (2018-10-01)

Association between Metformin Use and Clinical Outcomes Following Pancreaticoduodenectomy in Patients with Type 2 Diabetes and Pancreatic Ductal Adenocarcinoma
by: Daegwang Yoo, et al.
Published: (2020-06-01)

The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
by: Hyun Hee Chung, et al.
Published: (2013-04-01)

Protective effects of metformin on pancreatic β-cell ferroptosis in type 2 diabetes in vivo
by: Yue Sun, et al.
Published: (2023-12-01)

Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)

Association of metformin use with fracture risk in type 2 diabetes: A systematic review and meta-analysis of observational studies
by: Yining Wang, et al.
Published: (2023-01-01)

Clinical Efficacy of Different Doses of Canagliflozin Combined with Metformin in the Treatment of Type 2 Diabetes Mellitus: a Meta-analysis
by: Yuying CHEN, Xiaodong LI, Yunzhao TANG, Daiqing LI
Published: (2022-05-01)

The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
by: Maxime Parisotto, et al.
Published: (2022-11-01)

Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials
by: Ying Liu, et al.
Published: (2022-05-01)

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis
by: I-Li Lai, et al.
Published: (2023-07-01)

Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression
by: Razieh Bidhendi Yarandi, et al.
Published: (2019-07-01)

The effect of metformin use on hypopharyngeal squamous cell carcinoma in diabetes mellitus patients
by: Yung-An Tsou, et al.
Published: (2019-08-01)

Relationship between metformin use and mortality in tuberculosis patients with diabetes: a nationwide cohort study
by: Eunki Chung, et al.
Published: (2024-03-01)

Metformin versus insulin in the management of gestational diabetes mellitus
by: Ola Amer Mahmood
Published: (2019-01-01)

Effects of Metformin on Risk and Prognosis of Biliary Tract Cancer: A Systematic Review and Meta-Analysis
by: Junhong Chen, et al.
Published: (2023-02-01)

Multidimensional effects of metformin in patients with type 2 diabetes
by: Lyudmila A. Ruyatkina, et al.
Published: (2017-08-01)

The effects of metformin on anti-Müllerian hormone levels in patients with polycystic ovary syndrome: a systematic review and meta-analysis
by: Zhijiao Zhou, et al.
Published: (2023-06-01)

Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
by: Jixue Tan, et al.
Published: (2021-05-01)

Clinical Implication of Metformin in Relation to Diabetes Mellitus and Ovarian Cancer
by: Santosh Kumar Singh, et al.
Published: (2021-08-01)

Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies
by: Zhicheng Xu, et al.
Published: (2022-09-01)

The efficacy of metformin for the treatment of psoriasis: a meta-analysis study
by: Zhuo Huang, et al.
Published: (2023-08-01)

Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus
by: Chin‐Hsiao Tseng
Published: (2018-07-01)

Effect of Metformin on Diabetes Mellitus Prevention in Pregnant Women with Risk Factors
by: Shirin Niroomanesh, et al.
Published: (2010-12-01)

Comparison of Vildagliptin-Metformin and Glimepiride-Metformin Treatments in Type 2 Diabetic Patients
by: Hyun Jeong Jeon, et al.
Published: (2011-10-01)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis
by: Zhang Jingfan, et al.

Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis
by: Pajaree Mongkhon, et al.
Published: (2023-12-01)